Moving towards IMPROVED drug-free remission

被引：1

作者：

Bykerk, Vivian P. ^{[1
,2
]}

机构：

[1] Weill Cornell Med Coll, New York, NY 10065 USA

[2] Hosp Special Surg, Inflammatory Arthrit Ctr, 535 E 70th St, New York, NY 10021 USA

来源：

NATURE REVIEWS RHEUMATOLOGY | 2018年 / 14卷 / 04期

基金：

加拿大健康研究院; 美国国家卫生研究院;

关键词：

RHEUMATOID-ARTHRITIS;

D O I：

10.1038/nrrheum.2018.49

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The newly published 5-year outcomes of the IMPROVED trial demonstrate the feasibility of achieving long-term drug-free remission in early rheumatoid arthritis (RA). These findings raise the bar and support the use of a remission induction and maintenance approach, particularly in patients presenting with early joint inflammation consistent with early RA.

引用

页码：193 / 194

页数：2

共 50 条

[41] Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial
Muller, Petra Hissink
Brinkman, Danielle M. C.
Schonenberg-Meinema, Dieneke
van den Bosch, Wytse Bastiaan
Koopman-Keemink, Yvonne
Brederije, Isabel C. J.
Bekkering, Peter W.
Kuijpers, Taco W.
Van Rossum, Marion
van Suijlekom-Smit, Lisette W. A.
van den Berg, J. Merlijn
Boehringer, Stefan
Allaart, Cornelia F.
ten Cate, R.
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (01) : 51 - 59
[42] Long-term drug therapy of rheumatoid arthritis and remission
Pyai, L
Pyai, S
TERAPEVTICHESKII ARKHIV, 2000, 72 (05) : 21 - 25
[43] Long term drug related remission may encourage drug withdrawal in patients with rheumatoid arthritis
Tezcan, Mehmet Engin
MEDICAL HYPOTHESES, 2019, 125 : 89 - 89
[44] Are we moving in the right direction with osteoarthritis drug discovery?
Bondeson, Jan
EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (12) : 1355 - 1368
[45] Can remission be maintained with or without further drug therapy in rheumatoid arthritis?
Saleem, B.
Nizam, S.
Emery, P.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (06) : S33 - S36
[46] Moving towards disease modification in inflammatory bowel disease therapy
Allen, Patrick B.
Peyrin-Biroulet, Laurent
CURRENT OPINION IN GASTROENTEROLOGY, 2013, 29 (04) : 397 - 404
[47] Towards improved control of inflammatory bowel disease
Eberhardson, Michael
Hedin, Charlotte R. H.
Carlson, Marie
Tarnawski, Laura
Levine, Yaakov A.
Olofsson, Peder S.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2019, 89 (03)
[48] Low rates of biologic-free clinical disease activity index remission maintenance after biologic disease-modifying anti-rheumatic drug discontinuation while in remission in a Japanese multicentre rheumatoid arthritis registry
Yoshida, Kazuki
Kishimoto, Mitsumasa
Radner, Helga
Matsui, Kazuo
Okada, Masato
Saeki, Yukihiko
Solomon, Daniel H.
Tohma, Shigeto
RHEUMATOLOGY, 2016, 55 (02) : 286 - 290
[49] Drug free remission after steroid-dependent disappearance of lymphoproliferative disorder in rheumatoid arthritis patient treated with TNF-alpha blockade: case study
Oda, Kosaku
Minata, Mutsuko
SPRINGERPLUS, 2015, 4 : 1 - 5
[50] Prediction of long-term drug-free outcomes in ACPA-positive and ACPA-negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study
Manzo, Antonio
Cassione, Emanuele Bozzalla
Montecucco, Carlomaurizio
Sakellariou, Garifallia
Xoxi, Blerina
Luvaro, Terenzj
Sammali, Ylenia
De Stefano, Ludovico
Alpini, Claudia
Klersy, Catherine
Bugatti, Serena
RMD OPEN, 2025, 11 (01):

← 1 2 3 4 5 →